good point re tax losses and market cap. the other side of buying losers is that unless you have a plan to profitability,you are buying a liability that will be a drag on the P&L.
Has BUBs ever turned a profit? have the BUBs issues with their former CEO been resolved? is there a risk of adverse publicity and litigation? maybe there are reasons why it's market cap is $100m.
I would rather see 100m.spent on marketing to the elderly/US FDA, US marketing and the release of new products ie the recent new formula release announcement
if Nestle etc pick up BUBs they will have a drain on their P&L and not much to show for it. Nestle market share in China is way behind A2M. Nestle is better off buying out A2M and actually getting to top 5 spot in China
good point re tax losses and market cap. the other side of...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.53 |
Change
-0.030(0.46%) |
Mkt cap ! $4.724B | |||
| Open | High | Low | Value | Volume |
| $6.51 | $6.57 | $6.50 | $1.384M | 212.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 6389 | $6.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.54 | 2752 | 6 |
View Market Depth
| Last trade - 11.10am 25/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |